RAPP
Rapport Therapeutics, Inc. Common Stock · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers):
breedte van houders +30.0% ·
aandelenstroom +23.2% ·
netto nieuwe posities +20.0%
— formule
Brede accumulatie — stijgende aandelen bij meer houders
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 69 | +3 | 25.15M | $1.04B | +5 | −2 |
| Q1 2026 | 69 | +1 | 25.07M | $783.61M | +5 | −4 |
| Q4 2025 | 68 | +1 | 25.43M | $771.51M | +1 | — |
| Q3 2025 | 16 | +4 | 15.68M | $465.84M | +4 | — |
| Q2 2025 | 9 | +1 | 10.01M | $113.83M | +2 | −1 |
| Q1 2025 | 5 | 0 | 1.86M | $18.69M | +1 | −1 |
| Q4 2024 | 5 | 0 | 2.06M | $36.50M | — | — |
| Q3 2024 | 4 | -2 | 1.81M | $36.50M | +1 | −3 |
| Q2 2024 | 6 | — | 2.18M | $50.21M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 6.92M | +26.4% | $205.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 6.92M | +26.4% | $205.43M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | Goldman Sachs Group ✦ | 2.42M | — | $71.93M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Goldman Sachs Group ✦ | 2.42M | — | $71.93M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passief) | 1.63M | +46.9% | $48.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | The Vanguard Group ✦ (passief) | 1.63M | +46.9% | $48.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 7 | The Vanguard Group ✦ (passief) | 1.63M | +46.9% | $48.31M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 1.57M | +28.6% | $46.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 1.57M | +28.6% | $46.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 1.57M | +28.6% | $46.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 1.57M | +28.6% | $46.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 1.57M | +28.6% | $46.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 1.57M | +28.6% | $46.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 1.57M | +28.6% | $46.57M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 15 | T. Rowe Price ✦ | 1.10M | -27.7% | $32.74M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 16 | T. Rowe Price ✦ | 1.10M | -27.7% | $32.74M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passief) | 533.40K | +60.1% | $15.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 18 | Geode Capital Management ✦ (passief) | 533.40K | +60.1% | $15.85M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | Adage Capital Partners ✦ | 450.00K | Nieuw | $13.37M | 0.0% | New | 1 | SEC ↗ |
| 20 | State Street Global Advisors ✦ (passief) | 371.63K | +24.4% | $11.04M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 21 | Morgan Stanley ✦ | 274.57K | — | $8.15M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | Morgan Stanley ✦ | 274.57K | — | $8.15M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | Morgan Stanley ✦ | 274.57K | — | $8.15M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Morgan Stanley ✦ | 274.57K | — | $8.15M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Morgan Stanley ✦ | 274.57K | — | $8.15M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | Millennium Management ✦ | 154.17K | Nieuw | $4.58M | 0.0% | New | 1 | SEC ↗ |
| 27 | Citadel Advisors ✦ | 104.88K | Nieuw | $3.11M | 0.0% | New | 1 | SEC ↗ |
| 28 | Citadel Advisors ✦ | 104.88K | Nieuw | $3.11M | 0.0% | New | 1 | SEC ↗ |
| 29 | Wellington Management ✦ | 62.82K | Nieuw | $1.87M | 0.0% | New | 1 | SEC ↗ |
| 30 | Wellington Management ✦ | 62.82K | Nieuw | $1.87M | 0.0% | New | 1 | SEC ↗ |
| 31 | Wellington Management ✦ | 62.82K | Nieuw | $1.87M | 0.0% | New | 1 | SEC ↗ |
| 32 | Renaissance Technologies ✦ | 35.30K | +126.3% | $1.05M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 33 | Two Sigma Investments ✦ | 21.50K | +8.9% | $638,550 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 20.62K | +21.5% | $612,474 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 20.62K | +21.5% | $612,474 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 36 | AQR Capital Management ✦ | 20.62K | +21.5% | $612,474 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 37 | AQR Capital Management ✦ | 20.62K | +21.5% | $612,474 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 38 | JPMorgan Chase ✦ | 19.97K | — | $593,048 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 19.97K | — | $593,048 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 19.97K | — | $593,048 | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 19.97K | — | $593,048 | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 19.97K | — | $593,048 | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 19.97K | — | $593,048 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Adage Capital Partners | $13.37M | 0.0% |
| Millennium Management | $4.58M | 0.0% |
| Citadel Advisors | $3.11M | 0.0% |
| Citadel Advisors | $3.11M | 0.0% |
| Wellington Management | $1.87M | 0.0% |
| Wellington Management | $1.87M | 0.0% |
| Wellington Management | $1.87M | 0.0% |
Verlaten
| Geen bijgehouden uitstappen dit kwartaal. |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 146 houders, 52.47M aandelen, $1.59B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 404 aand · $20,160
Officer, Director · 3.66K aand · $171,837
Officer, Director · 19.50K aand · $936,846
Officer, Director · 5.79K aand · $281,721
Officer, Director · 14.17K aand · $651,492
Officer, Director · 8.37K aand · $391,280
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie